A growth-factor ligand binds a receptor tyrosine kinase (RTK) on the cell membrane, causing it to dimerize and autophosphorylate. This recruits adaptor proteins that switch the small GTPase Ras into its active, GTP-bound state. Active Ras recruits Raf to the membrane, which phosphorylates MEK, which in turn phosphorylates ERK. Active ERK translocates into the nucleus and phosphorylates transcription factors that switch on genes controlling cell growth, division and differentiation.
Mutations that lock Ras or Raf (e.g. KRAS G12D, BRAF V600E)
in their "always-on" state are among the most common drivers of human cancer, because
they keep this proliferation signal switched on regardless of receptor input.
A ligand binds a membrane receptor and triggers a Ras → Raf → MEK → ERK phosphorylation relay that amplifies at every step on its way to switching on genes in the nucleus.
Each kinase activates many copies of the next, so a handful of receptor-binding events can trigger a large, coordinated burst of active ERK — the biochemical basis of signal amplification.
Raise ligand concentration to trigger more pulses at the receptor, tune the amplification and speed sliders, and enable ERK negative feedback to see the cascade settle into damped oscillations instead of a steady glow.
Locked-on Ras or Raf mutations (KRAS G12D, BRAF V600E) are among the most common drivers of human cancer because they keep this proliferation signal running independent of any receptor input.